Want to see BSX full AI Analyst Report?
Operating Expense Breakdown
Breaks down spending on R&D, selling, manufacturing and corporate overhead, revealing how Boston Scientific balances investment in new devices and commercial expansion against cost control. High or rising expenses can signal heavy investment in future growth, while improving efficiency supports better margins and near-term profitability.SG&A and R&D have been climbing steadily — a deliberate commercial and product‑development push behind EP/PFA, WATCHMAN and the Penumbra strategy — while amortization rises reflect prior M&A. That steady investment baseline is punctuated by lumpy impairment, litigation and restructuring hits (notably mid‑2024 POLARx inventory/impairment and late‑2025 litigation), which inflate GAAP expense and increase volatility. Management is leaning on adjusted margins, FCF and buybacks, so focus on whether rising operating spend converts to durable share gains or simply pressures margins if episodic charges continue.
Date | Research and Development | Selling, General, and Administrative | Royalty Expense | Ammortization | Asset and Goodwill Impairment | Contingent Consideration Net Expense | Restructuring Net Charges | Litigation-related Net Charges | Loss on Disposal of Assets |
|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2026 | $554.00M | $1.80B | $12.00M | $233.00M | $0.00 | -$16.00M | $8.00M | $76.00M | $0.00 |
Mar 31, 2026 | $516.00M | $1.78B | $12.00M | $232.00M | $0.00 | -$30.00M | $3.00M | $0.00 | $0.00 |
Dec 31, 2025 | $569.00M | $1.83B | $6.00M | $228.00M | $0.00 | $7.00M | $16.00M | $194.00M | $0.00 |
Sep 30, 2025 | $514.00M | $1.74B | $12.00M | $225.00M | $0.00 | $11.00M | -$8.00M | $0.00 | $0.00 |
Jun 30, 2025 | $526.00M | $1.72B | $14.00M | $225.00M | $46.00M | -$5.00M | $83.00M | $0.00 | $0.00 |
Mar 31, 2025 | $443.00M | $1.60B | $14.00M | $219.00M | $0.00 | $5.00M | $10.00M | $0.00 | $0.00 |
Dec 31, 2024 | $460.00M | $1.61B | $10.00M | $225.00M | $111.00M | -$1.00M | $4.00M | $0.00 | $0.00 |
Sep 30, 2024 | $407.00M | $1.56B | $5.00M | $205.00M | $0.00 | -$23.00M | $8.00M | $0.00 | $0.00 |
Jun 30, 2024 | $383.00M | $1.45B | $9.00M | $213.00M | $276.00M | $2.00M | $1.00M | $0.00 | $0.00 |
Mar 31, 2024 | $366.00M | $1.36B | $10.00M | $214.00M | $0.00 | $17.00M | $3.00M | $0.00 | $0.00 |